US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Kymera Therapeutics, Inc.

117.64

-1.1700-0.98%

Volume:279.84K

Turnover:32.86M

Market Cap:9.78B

PE:-36.62

High:118.55

Open:116.92

Low:116.28

Close:118.81

52wk High:130.05

52wk Low:39.84

Shares:83.15M

Float Shares:64.87M

Volume Ratio:0.51

T/O Rate:0.43%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.2122

EPS(LYR):-3.6900

ROE:-24.15%

ROA:-15.59%

PB:6.48

PE(LYR):-31.88

Loading ...

Overview Company News Filings

Kymera Therapeutics Chief Business Officer Noah Goodman sells 1,347 shares for $121,230

Kymera director Bruce Booth disposes of common shares worth $836,290.08

BUZZ-U.S. STOCKS ON THE MOVE-Conagra, Oracle, Replimune

BUZZ-U.S. STOCKS ON THE MOVE-Allogene Therapeutics, Adobe, Williams-Sonoma

FDA grants fast track designation to Kymera Therapeutics KT-621

Kymera says FDA grants Fast Track designation for KT-621 in eosinophilic asthma

Kymera Therapeutics Inc - KT-621 Broaden2 Phase 2B Atopic Dermatitis Trial Ongoing, Data Expected by Mid-2027

THOMSON REUTERS

Kymera Therapeutics Announces U.S. FDA Fast Track Designation for KT-621, a First-in-Class, Oral Stat6 Degrader for the Treatment of Moderate to Severe Asthma

THOMSON REUTERS

Kymera CBO Noah Goodman disposes of common shares worth $893,260.62

BUZZ-U.S. STOCKS ON THE MOVE-Amazon, Northrop Grumman, Brown-Forman

BUZZ-Kymera rises as Gilead pays $45 million for experimental cancer drug

Kymera Therapeutics Inc - Gilead to Advance KT-200 Into Ind-Enabling Studies for 2027 Ind Filing

THOMSON REUTERS

Kymera Therapeutics Inc - to Receive $45 Mln Milestone Payment From Gilead for KT-200 Option

THOMSON REUTERS

Kymera Therapeutics Inc - May Receive Tiered Royalties From High Single-Digit to Mid-Teens on Sales

THOMSON REUTERS

Kymera Therapeutics Inc - Eligible for up to $750 Mln in Total Payments Under Agreement

THOMSON REUTERS

Kymera Therapeutics Announces Gilead Sciences’ Option Exercise to License KT-200, Oral CDK2 Molecular Glue Degrader Development Candidate

Kymera COO Jeremy G Chadwick disposes of USD 1.9 million common shares

Kymera director Elena Ridloff disposes of USD 1.3 million common shares

How Investors Are Reacting To Kymera Therapeutics (KYMR) Oral STAT6 Degrader’s Positive Phase 1b Atopic Dermatitis Data

Simply Wall St.

Kymera says oral STAT6 degrader KT-621 shows positive Phase 1b atopic dermatitis data

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/KYMR/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KYMR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KYMR\",,,,,undefined,":{"symbol":"KYMR","market":"US","secType":"STK","nameCN":"Kymera Therapeutics, Inc.","latestPrice":117.64,"timestamp":1788289646003,"preClose":118.81,"halted":0,"volume":279836,"delay":0,"changeRate":-0.009847655921218766,"floatShares":64874597,"shares":83150618,"eps":-3.212195,"marketStatus":"Trading","change":-1.17,"latestTime":"09-01 15:07:34 EDT","open":116.92,"high":118.55,"low":116.28,"amount":32862569.762943998,"amplitude":0.019106,"askPrice":117.83,"askSize":290,"bidPrice":117.54,"bidSize":53,"shortable":3,"etf":0,"ttmEps":-3.212195,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788292800000},"marketStatusCode":2,"adr":0,"listingDate":1597982400000,"exchange":"NASDAQ","adjPreClose":118.81,"preHourTrading":{"tag":"盘前","latestPrice":116.5,"preClose":118.81,"latestTime":"09:23 EDT","volume":492,"amount":58242.025200000004,"timestamp":1788269013409,"change":-2.31,"changeRate":-0.019443,"amplitude":0.042337},"postHourTrading":{"tag":"盘后","latestPrice":118.81,"preClose":118.81,"latestTime":"19:30 EDT","volume":36177,"amount":4298165.16092,"timestamp":1788219002306,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.512102,"impliedVol":0.4984,"impliedVolPercentile":0.0556},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KYMR\",,,,,undefined,":{"symbol":"KYMR","floatShares":64874597,"roa":"-15.59%","roe":"-24.15%","lyrEps":-3.69,"volumeRatio":0.512102,"shares":83150618,"dividePrice":0,"high":118.55,"amplitude":0.019106,"preClose":118.81,"low":116.28,"week52Low":39.84,"pbRate":"6.48","psRate":"93.16","week52High":130.05,"institutionHeld":0,"latestPrice":117.64,"committee":-0.690962,"eps":-3.212195,"divideRate":0,"volume":279836,"delay":0,"ttmEps":-3.212195,"open":116.92,"prevYearClose":77.81,"prevWeekClose":118.15,"prevMonthClose":118.81,"prevQuarterClose":114.67,"fiveDayClose":126.64,"twentyDayClose":104.39,"sixtyDayClose":74.13},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KYMR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-05","symbol":"KYMR","fiscalQuarterEnding":"2026/06","expectedEps":-0.64,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785902400000,"reportTimeType":"pre","actualEps":-0.62},{"market":"US","date":"2026-04-30","symbol":"KYMR","fiscalQuarterEnding":"2026/03","expectedEps":-0.89,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1777521600000,"reportTimeType":"pre","actualEps":-0.71},{"market":"US","date":"2026-02-26","symbol":"KYMR","fiscalQuarterEnding":"2025/12","expectedEps":-0.77,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1772082000000,"reportTimeType":"pre","actualEps":-0.97},{"market":"US","date":"2025-11-04","symbol":"KYMR","fiscalQuarterEnding":"2025/09","expectedEps":-0.71,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762232400000,"reportTimeType":"pre","actualEps":-0.9},{"market":"US","date":"2025-08-11","symbol":"KYMR","fiscalQuarterEnding":"2025/06","expectedEps":-0.83,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"pre","actualEps":-0.95}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KYMR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KYMR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.5417,"hold":0.125,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5417,"analysts":24,"updateTime":1785556800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/KYMR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"KYMR","date":"2026-08-31","current":-36.630715,"percent":0.081862,"low":-58.167912,"twenty":-21.396942,"median":-13.721078,"eighty":-9.106984,"high":-3.789687,"avg":-16.676766,"sd":10.437135,"marketCap":9824245516},"quantilePoints":[{"date":"2021-09-03","current":-52.39126,"twenty":-60.097568,"median":-46.12249,"eighty":-34.975392,"marketCap":3060016351},{"date":"2021-09-10","current":-58.167912,"twenty":-59.789796,"median":-46.231492,"eighty":-35.068445,"marketCap":3397413224},{"date":"2021-09-17","current":-54.930544,"twenty":-59.674378,"median":-46.53986,"eighty":-35.246583,"marketCap":3208328270},{"date":"2021-09-24","current":-54.537871,"twenty":-59.587037,"median":-46.809695,"eighty":-35.522327,"marketCap":3185393437},{"date":"2021-10-01","current":-52.54833,"twenty":-59.317994,"median":-46.890871,"eighty":-35.686253,"marketCap":3069190284},{"date":"2021-10-08","current":-48.51689,"twenty":-59.054061,"median":-47.083511,"eighty":-35.748479,"marketCap":2833726002},{"date":"2021-10-15","current":-49.91306,"twenty":-58.876157,"median":-47.068364,"eighty":-35.81053,"marketCap":2915272074},{"date":"2021-10-22","current":-48.586699,"twenty":-58.513954,"median":-47.083511,"eighty":-35.888209,"marketCap":2837803305},{"date":"2021-10-29","current":-51.379038,"twenty":-58.231387,"median":-47.634572,"eighty":-36.031291,"marketCap":3000895449},{"date":"2021-11-05","current":-56.66703,"twenty":-57.962548,"median":-47.834805,"eighty":-36.268304,"marketCap":3309751197},{"date":"2021-11-12","current":-40.862951,"twenty":-57.592374,"median":-47.792627,"eighty":-36.643399,"marketCap":3228254889},{"date":"2021-11-19","current":-39.959795,"twenty":-57.394247,"median":-47.611037,"eighty":-37.018397,"marketCap":3156903732},{"date":"2021-11-26","current":-34.950201,"twenty":-57.231083,"median":-47.083511,"eighty":-36.522189,"marketCap":2761135800},{"date":"2021-12-03","current":-34.534359,"twenty":-57.176853,"median":-46.939001,"eighty":-35.85679,"marketCap":2728283469},{"date":"2021-12-10","current":-34.469384,"twenty":-57.023938,"median":-46.854693,"eighty":-35.731094,"marketCap":2723150292},{"date":"2021-12-17","current":-35.067157,"twenty":-56.895652,"median":-46.777903,"eighty":-35.441994,"marketCap":2770375518},{"date":"2021-12-23","current":-40.135228,"twenty":-56.832825,"median":-46.53986,"eighty":-35.508989,"marketCap":3170763309},{"date":"2021-12-31","current":-41.252803,"twenty":-56.832825,"median":-46.231492,"eighty":-35.541476,"marketCap":3259053950},{"date":"2022-01-07","current":-36.100264,"twenty":-56.728112,"median":-46.187032,"eighty":-35.667949,"marketCap":2851993030},{"date":"2022-01-14","current":-26.685346,"twenty":-56.71066,"median":-46.004337,"eighty":-35.425245,"marketCap":2108195711},{"date":"2022-01-21","current":-24.716595,"twenty":-56.675756,"median":-45.799762,"eighty":-35.072355,"marketCap":1952660454},{"date":"2022-01-28","current":-25.002486,"twenty":-56.639106,"median":-45.704713,"eighty":-34.970993,"marketCap":1975246432},{"date":"2022-02-04","current":-25.814677,"twenty":-56.535547,"median":-45.445318,"eighty":-34.855337,"marketCap":2039411142},{"date":"2022-02-11","current":-27.315606,"twenty":-56.458749,"median":-45.224602,"eighty":-34.521364,"marketCap":2157987526},{"date":"2022-02-18","current":-25.210407,"twenty":-56.1271,"median":-44.939951,"eighty":-34.265806,"marketCap":1991672598},{"date":"2022-02-25","current":-20.657659,"twenty":-56.016065,"median":-44.903954,"eighty":-33.945704,"marketCap":2070248565},{"date":"2022-03-04","current":-18.502704,"twenty":-55.854061,"median":-44.772733,"eighty":-33.283828,"marketCap":1854285526},{"date":"2022-03-11","current":-19.812174,"twenty":-55.682188,"median":-44.495341,"eighty":-32.324854,"marketCap":1985516655},{"date":"2022-03-18","current":-22.317695,"twenty":-55.576416,"median":-44.339691,"eighty":-30.931725,"marketCap":2236612438},{"date":"2022-03-25","current":-20.843253,"twenty":-55.509604,"median":-44.227687,"eighty":-29.91279,"marketCap":2088848253},{"date":"2022-04-01","current":-21.477366,"twenty":-55.415713,"median":-43.894478,"eighty":-29.09307,"marketCap":2152397186},{"date":"2022-04-08","current":-18.368664,"twenty":-55.256898,"median":-43.540327,"eighty":-28.991566,"marketCap":1840852418},{"date":"2022-04-14","current":-19.611114,"twenty":-55.165513,"median":-43.260183,"eighty":-28.567245,"marketCap":1965366993},{"date":"2022-04-22","current":-17.46647,"twenty":-55.132037,"median":-42.908771,"eighty":-28.180145,"marketCap":1750437270},{"date":"2022-04-29","current":-16.167875,"twenty":-55.087613,"median":-42.53692,"eighty":-27.835849,"marketCap":1620295970},{"date":"2022-05-06","current":-7.934642,"twenty":-55.003842,"median":-42.089758,"eighty":-27.620703,"marketCap":982514932},{"date":"2022-05-13","current":-7.267865,"twenty":-54.946251,"median":-41.906186,"eighty":-27.280132,"marketCap":899950652},{"date":"2022-05-20","current":-6.163516,"twenty":-54.905754,"median":-41.694372,"eighty":-27.026289,"marketCap":763203563},{"date":"2022-05-27","current":-6.271867,"twenty":-54.823551,"median":-41.430782,"eighty":-26.775569,"marketCap":776620258},{"date":"2022-06-03","current":-6.442729,"twenty":-54.717338,"median":-41.342758,"eighty":-26.099247,"marketCap":797777355},{"date":"2022-06-10","current":-6.209357,"twenty":-54.557652,"median":-41.120121,"eighty":-25.818576,"marketCap":768879857},{"date":"2022-06-17","current":-6.571917,"twenty":-54.511693,"median":-40.89219,"eighty":-25.245293,"marketCap":813774184},{"date":"2022-06-24","current":-8.388883,"twenty":-54.40698,"median":-40.800208,"eighty":-25.002486,"marketCap":1038761847},{"date":"2022-07-01","current":-8.793116,"twenty":-54.382983,"median":-40.668026,"eighty":-24.716595,"marketCap":1088816442},{"date":"2022-07-08","current":-10.985145,"twenty":-54.363863,"median":-40.651043,"eighty":-23.157688,"marketCap":1360246513},{"date":"2022-07-15","current":-9.680763,"twenty":-54.250803,"median":-40.300689,"eighty":-21.912481,"marketCap":1198730140},{"date":"2022-07-22","current":-9.047325,"twenty":-53.993365,"median":-40.141071,"eighty":-21.396942,"marketCap":1120294074},{"date":"2022-07-29","current":-9.18068,"twenty":-53.858983,"median":-39.89482,"eighty":-20.83088,"marketCap":1136806930},{"date":"2022-08-05","current":-12.989642,"twenty":-53.679227,"median":-39.157098,"eighty":-20.482375,"marketCap":1608455379},{"date":"2022-08-12","current":-12.493565,"twenty":-53.411973,"median":-38.789003,"eighty":-19.900847,"marketCap":1741890302},{"date":"2022-08-19","current":-11.838735,"twenty":-53.337979,"median":-38.465388,"eighty":-19.728657,"marketCap":1650591936},{"date":"2022-08-26","current":-12.117757,"twenty":-53.305752,"median":-38.163943,"eighty":-19.253329,"marketCap":1689493966},{"date":"2022-09-02","current":-10.712799,"twenty":-53.124249,"median":-37.899038,"eighty":-18.792437,"marketCap":1493610607},{"date":"2022-09-09","current":-11.456778,"twenty":-53.075383,"median":-37.802616,"eighty":-18.455274,"marketCap":1597338383},{"date":"2022-09-16","current":-10.113974,"twenty":-53.00383,"median":-37.690264,"eighty":-18.059341,"marketCap":1410120528},{"date":"2022-09-23","current":-8.466696,"twenty":-52.853783,"median":-37.393272,"eighty":-17.438079,"marketCap":1180452113},{"date":"2022-09-30","current":-8.497924,"twenty":-52.783961,"median":-37.338809,"eighty":-16.517073,"marketCap":1184806017},{"date":"2022-10-07","current":-7.928012,"twenty":-52.663514,"median":-36.555091,"eighty":-13.054653,"marketCap":1105347276},{"date":"2022-10-14","current":-8.587704,"twenty":-52.572763,"median":-36.180368,"eighty":-12.555718,"marketCap":1197323490},{"date":"2022-10-21","current":-9.758755,"twenty":-52.555311,"median":-36.074274,"eighty":-11.951943,"marketCap":1360594875},{"date":"2022-10-28","current":-11.706602,"twenty":-52.454088,"median":-35.903918,"eighty":-11.606672,"marketCap":1632169612},{"date":"2022-11-04","current":-10.95052,"twenty":-52.280562,"median":-35.713709,"eighty":-11.366217,"marketCap":1684660854},{"date":"2022-11-11","current":-10.961165,"twenty":-52.141445,"median":-35.525233,"eighty":-11.186385,"marketCap":1686298568},{"date":"2022-11-18","current":-10.233733,"twenty":-52.033077,"median":-35.425245,"eighty":-11.029695,"marketCap":1574388174},{"date":"2022-11-25","current":-9.854049,"twenty":-51.965429,"median":-35.127475,"eighty":-10.972797,"marketCap":1515976407},{"date":"2022-12-02","current":-10.922132,"twenty":-51.872694,"median":-35.050913,"eighty":-10.933487,"marketCap":1680293620},{"date":"2022-12-09","current":-9.190488,"twenty":-51.760368,"median":-34.976191,"eighty":-10.762271,"marketCap":1413892292},{"date":"2022-12-16","current":-10.027923,"twenty":-51.690661,"median":-34.886786,"eighty":-10.631224,"marketCap":1542725721},{"date":"2022-12-23","current":-9.396298,"twenty":-51.643683,"median":-34.761773,"eighty":-10.461765,"marketCap":1445554745},{"date":"2022-12-30","current":-8.856934,"twenty":-51.58372,"median":-34.61629,"eighty":-10.350133,"marketCap":1362577282},{"date":"2023-01-06","current":-9.697917,"twenty":-51.379038,"median":-34.469384,"eighty":-10.297605,"marketCap":1491956615},{"date":"2023-01-13","current":-12.25635,"twenty":-51.256873,"median":-34.303957,"eighty":-10.297605,"marketCap":1885553659},{"date":"2023-01-20","current":-12.419579,"twenty":-51.251155,"median":-34.181877,"eighty":-10.303283,"marketCap":1910665260},{"date":"2023-01-27","current":-13.076042,"twenty":-51.153931,"median":-33.917788,"eighty":-10.324573,"marketCap":2011657566},{"date":"2023-02-03","current":-13.182496,"twenty":-51.098859,"median":-33.526965,"eighty":-10.344455,"marketCap":2028034697},{"date":"2023-02-10","current":-11.780858,"twenty":-51.090271,"median":-32.866801,"eighty":-10.35598,"marketCap":1812402475},{"date":"2023-02-17","current":-11.947635,"twenty":-51.021067,"median":-32.298777,"eighty":-10.366287,"marketCap":1838059980},{"date":"2023-02-24","current":-11.157115,"twenty":-50.808509,"median":-31.070369,"eighty":-10.408947,"marketCap":1727210659},{"date":"2023-03-03","current":-11.639431,"twenty":-50.542187,"median":-30.891255,"eighty":-10.455157,"marketCap":1801877108},{"date":"2023-03-10","current":-10.49393,"twenty":-50.361636,"median":-30.284071,"eighty":-10.48353,"marketCap":1624544291},{"date":"2023-03-17","current":-11.008164,"twenty":-50.140894,"median":-29.544301,"eighty":-10.497824,"marketCap":1704151903},{"date":"2023-03-24","current":-10.401722,"twenty":-50.020892,"median":-29.090731,"eighty":-10.455157,"marketCap":1610269823},{"date":"2023-03-31","current":-10.508116,"twenty":-49.98944,"median":-28.999526,"eighty":-10.388384,"marketCap":1626740363},{"date":"2023-04-06","current":-10.586137,"twenty":-49.949709,"median":-28.985983,"eighty":-10.415431,"marketCap":1638818759},{"date":"2023-04-14","current":-11.841579,"twenty":-49.849014,"median":-28.581203,"eighty":-10.448769,"marketCap":1833171135},{"date":"2023-04-21","current":-12.008262,"twenty":-49.732136,"median":-28.390444,"eighty":-10.474075,"marketCap":1858974981},{"date":"2023-04-28","current":-11.157632,"twenty":-49.657868,"median":-28.116374,"eighty":-10.487547,"marketCap":1727290638},{"date":"2023-05-05","current":-9.075289,"twenty":-49.553375,"median":-27.841432,"eighty":-10.487547,"marketCap":1443442877},{"date":"2023-05-12","current":-9.718931,"twenty":-49.490296,"median":-27.737946,"eighty":-10.381714,"marketCap":1545815421},{"date":"2023-05-19","current":-10.225916,"twenty":-49.450579,"median":-27.590189,"eighty":-10.319099,"marketCap":1626452351},{"date":"2023-05-26","current":-9.987943,"twenty":-49.384446,"median":-27.302611,"eighty":-10.268406,"marketCap":1588602363},{"date":"2023-06-02","current":-10.139694,"twenty":-49.354964,"median":-27.236588,"eighty":-10.236831,"marketCap":1612738587},{"date":"2023-06-08","current":-8.746348,"twenty":-49.319688,"median":-27.124925,"eighty":-10.222467,"marketCap":1391124169},{"date":"2023-06-16","current":-9.543038,"twenty":-49.101536,"median":-26.951745,"eighty":-10.153489,"marketCap":1517839344},{"date":"2023-06-23","current":-8.080715,"twenty":-48.944671,"median":-26.910903,"eighty":-10.113974,"marketCap":1285253915},{"date":"2023-06-30","current":-7.725481,"twenty":-48.714201,"median":-26.678849,"eighty":-10.083132,"marketCap":1228753209},{"date":"2023-07-07","current":-7.642708,"twenty":-48.581174,"median":-26.094071,"eighty":-10.029342,"marketCap":1215587996},{"date":"2023-07-14","current":-7.687543,"twenty":-48.550488,"median":-25.843916,"eighty":-9.996276,"marketCap":1222719153},{"date":"2023-07-21","current":-7.418531,"twenty":-48.452515,"median":-25.736707,"eighty":-9.976784,"marketCap":1179932211},{"date":"2023-07-28","current":-7.642708,"twenty":-48.322595,"median":-25.297621,"eighty":-9.91863,"marketCap":1215587996},{"date":"2023-08-04","current":-8.325772,"twenty":-48.26907,"median":-25.145432,"eighty":-9.856413,"marketCap":1312091662},{"date":"2023-08-11","current":-7.046225,"twenty":-48.239401,"median":-24.892029,"eighty":-9.804457,"marketCap":1110442734},{"date":"2023-08-18","current":-6.596466,"twenty":-48.152272,"median":-24.716595,"eighty":-9.765337,"marketCap":1039563411},{"date":"2023-08-25","current":-6.746385,"twenty":-48.032791,"median":-23.741966,"eighty":-9.707694,"marketCap":1063189852},{"date":"2023-09-01","current":-6.65225,"twenty":-47.951039,"median":-22.317695,"eighty":-9.667636,"marketCap":1048354644},{"date":"2023-09-08","current":-6.613898,"twenty":-47.924458,"median":-21.936196,"eighty":-9.572037,"marketCap":1042310671},{"date":"2023-09-15","current":-6.756845,"twenty":-47.90723,"median":-21.639761,"eighty":-9.529071,"marketCap":1064838208},{"date":"2023-09-22","current":-6.056058,"twenty":-47.860111,"median":-21.384569,"eighty":-9.413184,"marketCap":954398332},{"date":"2023-09-29","current":-4.985701,"twenty":-47.781558,"median":-20.887073,"eighty":-9.333925,"marketCap":785716531},{"date":"2023-10-06","current":-5.484271,"twenty":-47.716741,"median":-20.688591,"eighty":-9.24394,"marketCap":864288184},{"date":"2023-10-13","current":-4.351157,"twenty":-47.625158,"median":-20.459176,"eighty":-9.174333,"marketCap":685716245},{"date":"2023-10-20","current":-4.145453,"twenty":-47.489734,"median":-20.157585,"eighty":-9.106984,"marketCap":653298570},{"date":"2023-10-27","current":-4.012966,"twenty":-47.294195,"median":-19.910127,"eighty":-9.072011,"marketCap":632419390},{"date":"2023-11-03","current":-3.963586,"twenty":-47.080481,"median":-19.830218,"eighty":-8.938402,"marketCap":663738160},{"date":"2023-11-10","current":-4.696304,"twenty":-47.063128,"median":-19.683289,"eighty":-8.857001,"marketCap":786438288},{"date":"2023-11-17","current":-5.904393,"twenty":-46.987256,"median":-19.373965,"eighty":-8.803369,"marketCap":988743705},{"date":"2023-11-24","current":-6.540402,"twenty":-46.919749,"median":-19.080109,"eighty":-8.726901,"marketCap":1095249134},{"date":"2023-12-01","current":-6.805952,"twenty":-46.878192,"median":-18.817183,"eighty":-8.686608,"marketCap":1139717896},{"date":"2023-12-08","current":-7.763244,"twenty":-46.855589,"median":-18.510438,"eighty":-8.598634,"marketCap":1300025038},{"date":"2023-12-15","current":-8.34352,"twenty":-46.846723,"median":-18.368664,"eighty":-8.460015,"marketCap":1397197517},{"date":"2023-12-22","current":-8.294344,"twenty":-46.816053,"median":-18.030986,"eighty":-8.361665,"marketCap":1388962561},{"date":"2023-12-29","current":-8.79266,"twenty":-46.777903,"median":-17.79126,"eighty":-8.388883,"marketCap":1472410114},{"date":"2024-01-05","current":-8.923796,"twenty":-46.766793,"median":-17.452275,"eighty":-8.343329,"marketCap":1494369997},{"date":"2024-01-12","current":-9.674507,"twenty":-46.627671,"median":-17.043728,"eighty":-8.370738,"marketCap":1620083291},{"date":"2024-01-19","current":-9.548135,"twenty":-46.523894,"median":-16.749871,"eighty":-8.403522,"marketCap":1598921100},{"date":"2024-01-26","current":-11.176934,"twenty":-46.396169,"median":-14.953625,"eighty":-8.429475,"marketCap":1871678229},{"date":"2024-02-02","current":-11.471803,"twenty":-46.233294,"median":-13.281852,"eighty":-8.443505,"marketCap":1921056675},{"date":"2024-02-09","current":-11.928148,"twenty":-46.219098,"median":-13.205561,"eighty":-8.460015,"marketCap":1997475698},{"date":"2024-02-16","current":-13.135706,"twenty":-46.203228,"median":-13.097993,"eighty":-8.479187,"marketCap":2199692190},{"date":"2024-02-23","current":-16.837086,"twenty":-46.159109,"median":-13.182496,"eighty":-8.497945,"marketCap":2474411842},{"date":"2024-03-01","current":-17.756077,"twenty":-46.044123,"median":-13.272981,"eighty":-8.508435,"marketCap":2609468650},{"date":"2024-03-08","current":-17.756077,"twenty":-46.020308,"median":-13.374413,"eighty":-8.557588,"marketCap":2609468650},{"date":"2024-03-15","current":-16.42957,"twenty":-45.949772,"median":-13.662373,"eighty":-8.593169,"marketCap":2414522397},{"date":"2024-03-22","current":-16.974311,"twenty":-45.822699,"median":-16.167875,"eighty":-8.619808,"marketCap":2494578695},{"date":"2024-03-28","current":-16.704019,"twenty":-45.761534,"median":-16.421253,"eighty":-8.638924,"marketCap":2454856105},{"date":"2024-04-05","current":-15.069795,"twenty":-45.711642,"median":-16.371353,"eighty":-8.670473,"marketCap":2214687210},{"date":"2024-04-12","current":-15.473153,"twenty":-45.704713,"median":-16.157001,"eighty":-8.686608,"marketCap":2273965538},{"date":"2024-04-19","current":-14.604062,"twenty":-45.657644,"median":-15.55632,"eighty":-8.686608,"marketCap":2146242131},{"date":"2024-04-26","current":-13.923994,"twenty":-45.5064,"median":-15.136328,"eighty":-8.687717,"marketCap":2046298037},{"date":"2024-05-03","current":-14.407727,"twenty":-45.384235,"median":-14.959599,"eighty":-8.704809,"marketCap":2227304910},{"date":"2024-05-10","current":-15.324582,"twenty":-45.271672,"median":-15.123853,"eighty":-8.713937,"marketCap":2369042495},{"date":"2024-05-17","current":-14.129892,"twenty":-45.224602,"median":-15.056286,"eighty":-8.746348,"marketCap":2184354127},{"date":"2024-05-24","current":-13.590098,"twenty":-45.023652,"median":-14.844325,"eighty":-8.77228,"marketCap":2100906890},{"date":"2024-05-31","current":-12.744686,"twenty":-44.975332,"median":-14.700565,"eighty":-8.788584,"marketCap":1970213792},{"date":"2024-06-07","current":-13.082057,"twenty":-44.925971,"median":-14.537498,"eighty":-8.793025,"marketCap":2022368315},{"date":"2024-06-14","current":-13.213037,"twenty":-44.906953,"median":-14.383912,"eighty":-8.797997,"marketCap":2042616541},{"date":"2024-06-21","current":-12.697057,"twenty":-44.90384,"median":-14.292624,"eighty":-8.805809,"marketCap":1962850801},{"date":"2024-06-28","current":-11.847676,"twenty":-44.881476,"median":-14.217211,"eighty":-8.812693,"marketCap":1831544120},{"date":"2024-07-05","current":-12.006439,"twenty":-44.829216,"median":-14.127873,"eighty":-8.814742,"marketCap":1856087425},{"date":"2024-07-12","current":-16.789169,"twenty":-44.745164,"median":-14.169583,"eighty":-8.831969,"marketCap":2595454482},{"date":"2024-07-19","current":-17.106695,"twenty":-44.652302,"median":-14.288247,"eighty":-8.856979,"marketCap":2644541092},{"date":"2024-07-26","current":-17.678241,"twenty":-44.511281,"median":-14.383912,"eighty":-8.863292,"marketCap":2732896989},{"date":"2024-08-02","current":-16.685974,"twenty":-44.415386,"median":-14.439331,"eighty":-8.882836,"marketCap":2579501334},{"date":"2024-08-09","current":-16.211527,"twenty":-44.384878,"median":-14.691387,"eighty":-8.906376,"marketCap":2559054389},{"date":"2024-08-16","current":-17.13477,"twenty":-44.303137,"median":-14.819835,"eighty":-8.920794,"marketCap":2704792043},{"date":"2024-08-23","current":-19.297835,"twenty":-44.240444,"median":-15.042778,"eighty":-8.934868,"marketCap":3046240465},{"date":"2024-08-30","current":-19.532091,"twenty":-44.22788,"median":-15.130091,"eighty":-8.97565,"marketCap":3083218688},{"date":"2024-09-06","current":-18.336578,"twenty":-44.194716,"median":-15.213448,"eighty":-9.018995,"marketCap":2894502242},{"date":"2024-09-13","current":-18.611223,"twenty":-44.032244,"median":-15.280922,"eighty":-9.051279,"marketCap":2937856020},{"date":"2024-09-20","current":-20.109653,"twenty":-43.886709,"median":-15.45652,"eighty":-9.068733,"marketCap":3174389133},{"date":"2024-09-27","current":-19.665374,"twenty":-43.807738,"median":-15.639486,"eighty":-9.079877,"marketCap":3104258021},{"date":"2024-10-04","current":-17.391477,"twenty":-43.585821,"median":-15.656,"eighty":-9.106984,"marketCap":2745314241},{"date":"2024-10-11","current":-18.1831,"twenty":-43.426785,"median":-16.157001,"eighty":-9.143183,"marketCap":2870275131},{"date":"2024-10-18","current":-18.744507,"twenty":-43.269622,"median":-16.281044,"eighty":-9.152191,"marketCap":2958895353},{"date":"2024-10-25","current":-19.382652,"twenty":-43.188613,"median":-16.421253,"eighty":-9.17001,"marketCap":3059629132},{"date":"2024-11-01","current":-17.970803,"twenty":-42.953958,"median":-16.432042,"eighty":-9.174333,"marketCap":3009642282},{"date":"2024-11-08","current":-19.703301,"twenty":-42.897474,"median":-16.45452,"eighty":-9.181514,"marketCap":3299790710},{"date":"2024-11-15","current":-16.226703,"twenty":-42.824045,"median":-16.632072,"eighty":-9.185976,"marketCap":2717550897},{"date":"2024-11-22","current":-17.394593,"twenty":-42.641415,"median":-16.63794,"eighty":-9.198528,"marketCap":2913142024},{"date":"2024-11-29","current":-18.117756,"twenty":-42.362762,"median":-16.704019,"eighty":-9.230689,"marketCap":3034253086},{"date":"2024-12-06","current":-18.048147,"twenty":-42.117999,"median":-16.760212,"eighty":-9.274328,"marketCap":3022595337},{"date":"2024-12-13","current":-16.292445,"twenty":-42.089758,"median":-16.770553,"eighty":-9.296942,"marketCap":2728560993},{"date":"2024-12-20","current":-15.723969,"twenty":-42.026009,"median":-16.710256,"eighty":-9.297366,"marketCap":2633356040},{"date":"2024-12-27","current":-15.511274,"twenty":-41.948978,"median":-16.669034,"eighty":-9.299865,"marketCap":2597735140},{"date":"2025-01-03","current":-16.083617,"twenty":-41.901479,"median":-16.632072,"eighty":-9.317721,"marketCap":2693587745},{"date":"2025-01-10","current":-14.761041,"twenty":-41.841229,"median":-16.510768,"eighty":-9.338641,"marketCap":2472090508},{"date":"2025-01-17","current":-15.704633,"twenty":-41.745207,"median":-16.439891,"eighty":-9.354352,"marketCap":2630117777},{"date":"2025-01-24","current":-17.154827,"twenty":-41.651541,"median":-16.567015,"eighty":-9.358228,"marketCap":2872987554},{"date":"2025-01-31","current":-15.310181,"twenty":-41.477861,"median":-16.437202,"eighty":-9.370749,"marketCap":2564057197},{"date":"2025-02-07","current":-14.43233,"twenty":-41.453375,"median":-16.425411,"eighty":-9.413184,"marketCap":2417040025},{"date":"2025-02-14","current":-14.262174,"twenty":-41.388207,"median":-16.396436,"eighty":-9.48073,"marketCap":2388543305},{"date":"2025-02-21","current":-14.235104,"twenty":-41.36853,"median":-16.354374,"eighty":-9.48073,"marketCap":2384009735},{"date":"2025-02-28","current":-9.095045,"twenty":-41.316985,"median":-16.292445,"eighty":-9.48073,"marketCap":2035998663},{"date":"2025-03-07","current":-9.54182,"twenty":-41.252803,"median":-16.219115,"eighty":-9.364362,"marketCap":2136012633},{"date":"2025-03-14","current":-9.971187,"twenty":-41.120121,"median":-16.157001,"eighty":-9.396298,"marketCap":2232129954},{"date":"2025-03-21","current":-9.44028,"twenty":-41.064375,"median":-15.882524,"eighty":-9.44028,"marketCap":2113282185},{"date":"2025-03-28","current":-8.59315,"twenty":-40.921429,"median":-15.785844,"eighty":-9.356694,"marketCap":1923645308},{"date":"2025-04-04","current":-6.402796,"twenty":-40.862951,"median":-15.746717,"eighty":-9.297366,"marketCap":1433317081},{"date":"2025-04-11","current":-6.997528,"twenty":-40.836961,"median":-15.704633,"eighty":-9.230689,"marketCap":1566452560},{"date":"2025-04-17","current":-7.534237,"twenty":-40.778157,"median":-15.657984,"eighty":-9.184014,"marketCap":1686599211},{"date":"2025-04-25","current":-9.649161,"twenty":-40.687293,"median":-15.64736,"eighty":-9.172062,"marketCap":2160041963},{"date":"2025-05-02","current":-10.262501,"twenty":-40.668071,"median":-15.580884,"eighty":-9.179093,"marketCap":2297342930},{"date":"2025-05-09","current":-8.129065,"twenty":-40.65763,"median":-15.513208,"eighty":-9.146726,"marketCap":1958145409},{"date":"2025-05-16","current":-8.177726,"twenty":-40.651841,"median":-15.473153,"eighty":-9.07365,"marketCap":1969866932},{"date":"2025-05-23","current":-8.156099,"twenty":-40.649035,"median":-15.377323,"eighty":-8.951301,"marketCap":1964657366},{"date":"2025-05-30","current":-8.177726,"twenty":-40.441912,"median":-15.295552,"eighty":-8.913864,"marketCap":1969866932},{"date":"2025-06-06","current":-12.884311,"twenty":-40.299994,"median":-15.236704,"eighty":-8.913864,"marketCap":3103598610},{"date":"2025-06-13","current":-12.784286,"twenty":-40.274094,"median":-15.203654,"eighty":-8.921794,"marketCap":3079504370},{"date":"2025-06-20","current":-12.554499,"twenty":-40.211637,"median":-15.136243,"eighty":-8.934518,"marketCap":3024152737},{"date":"2025-06-27","current":-12.357152,"twenty":-40.138734,"median":-15.10522,"eighty":-8.95095,"marketCap":2976615453},{"date":"2025-07-03","current":-13.046424,"twenty":-40.100141,"median":-15.069795,"eighty":-8.963563,"marketCap":3142648605},{"date":"2025-07-11","current":-13.168761,"twenty":-39.933805,"median":-14.938931,"eighty":-9.018995,"marketCap":3172117514},{"date":"2025-07-18","current":-13.50082,"twenty":-39.812951,"median":-14.849403,"eighty":-9.051279,"marketCap":3252104551},{"date":"2025-07-25","current":-13.35518,"twenty":-39.627721,"median":-14.778193,"eighty":-9.068733,"marketCap":3217022517},{"date":"2025-08-01","current":-12.743493,"twenty":-39.147269,"median":-14.691387,"eighty":-9.07924,"marketCap":3069677975},{"date":"2025-08-08","current":-11.898781,"twenty":-39.064709,"median":-14.515474,"eighty":-9.095682,"marketCap":2866202177},{"date":"2025-08-15","current":-10.785615,"twenty":-38.850637,"median":-14.43233,"eighty":-9.106984,"marketCap":2970725155},{"date":"2025-08-22","current":-11.05558,"twenty":-38.768458,"median":-14.383912,"eighty":-9.124493,"marketCap":3045082656},{"date":"2025-08-29","current":-10.837532,"twenty":-38.768458,"median":-14.26484,"eighty":-9.124493,"marketCap":2985024674},{"date":"2025-09-05","current":-10.954343,"twenty":-38.809548,"median":-14.147693,"eighty":-9.115738,"marketCap":3017198593},{"date":"2025-09-12","current":-11.99267,"twenty":-38.768458,"median":-14.036722,"eighty":-9.124493,"marketCap":3303188981},{"date":"2025-09-19","current":-13.280194,"twenty":-38.768458,"median":-13.923994,"eighty":-9.124493,"marketCap":3657817062},{"date":"2025-09-26","current":-13.948617,"twenty":-38.768458,"median":-13.732985,"eighty":-9.124493,"marketCap":3841923374},{"date":"2025-10-03","current":-14.536569,"twenty":-38.768458,"median":-13.732985,"eighty":-9.124493,"marketCap":4003865432},{"date":"2025-10-10","current":-14.801343,"twenty":-38.768458,"median":-13.732985,"eighty":-9.124493,"marketCap":4076792980},{"date":"2025-10-17","current":-15.694303,"twenty":-38.768458,"median":-13.732985,"eighty":-9.124493,"marketCap":4322744714},{"date":"2025-10-24","current":-14.993433,"twenty":-38.768458,"median":-13.732985,"eighty":-9.124493,"marketCap":4129701202},{"date":"2025-10-31","current":-15.948693,"twenty":-38.768458,"median":-13.732985,"eighty":-9.124493,"marketCap":4392812359},{"date":"2025-11-07","current":-14.871445,"twenty":-38.510575,"median":-13.732985,"eighty":-9.124493,"marketCap":4388890647},{"date":"2025-11-14","current":-15.512624,"twenty":-37.938352,"median":-13.732985,"eighty":-9.124493,"marketCap":4578116588},{"date":"2025-11-21","current":-15.756418,"twenty":-37.652889,"median":-13.732985,"eighty":-9.124493,"marketCap":4650065615},{"date":"2025-11-28","current":-16.548749,"twenty":-37.32898,"median":-13.732985,"eighty":-9.124493,"marketCap":4883899952},{"date":"2025-12-05","current":-16.146489,"twenty":-36.08467,"median":-13.732985,"eighty":-9.124493,"marketCap":4765184058},{"date":"2025-12-12","current":-23.802748,"twenty":-35.592065,"median":-13.732985,"eighty":-9.124493,"marketCap":7024714560},{"date":"2025-12-19","current":-21.585387,"twenty":-35.069756,"median":-13.732985,"eighty":-9.124493,"marketCap":6370322520},{"date":"2025-12-26","current":-22.534135,"twenty":-34.960597,"median":-13.732985,"eighty":-9.124493,"marketCap":6650319114},{"date":"2026-01-02","current":-21.092037,"twenty":-34.674483,"median":-13.732985,"eighty":-9.124493,"marketCap":6224724290},{"date":"2026-01-09","current":-20.324906,"twenty":-33.447973,"median":-13.732985,"eighty":-9.124493,"marketCap":5998327044},{"date":"2026-01-16","current":-19.278572,"twenty":-29.680357,"median":-13.732985,"eighty":-9.124493,"marketCap":5689530800},{"date":"2026-01-23","current":-19.725839,"twenty":-27.736646,"median":-13.732985,"eighty":-9.124493,"marketCap":5821529194},{"date":"2026-01-30","current":-20.03486,"twenty":-26.936151,"median":-13.732985,"eighty":-9.124493,"marketCap":5912728085},{"date":"2026-02-06","current":-20.585135,"twenty":-25.879653,"median":-13.732985,"eighty":-9.124493,"marketCap":6075126110},{"date":"2026-02-13","current":-22.775389,"twenty":-25.350754,"median":-13.732985,"eighty":-9.124493,"marketCap":6721518248},{"date":"2026-02-20","current":-23.447645,"twenty":-24.971298,"median":-13.732985,"eighty":-9.124493,"marketCap":6919915835},{"date":"2026-02-27","current":-24.821424,"twenty":-24.616503,"median":-13.732985,"eighty":-9.124493,"marketCap":7728175245},{"date":"2026-03-06","current":-21.900597,"twenty":-23.960592,"median":-13.732985,"eighty":-9.124493,"marketCap":6818772746},{"date":"2026-03-13","current":-20.322034,"twenty":-23.398123,"median":-13.732985,"eighty":-9.124493,"marketCap":6327285535},{"date":"2026-03-20","current":-20.864829,"twenty":-22.914822,"median":-13.732985,"eighty":-9.124493,"marketCap":6496285290},{"date":"2026-03-27","current":-21.024783,"twenty":-22.604919,"median":-13.732985,"eighty":-9.124493,"marketCap":6546087150},{"date":"2026-04-02","current":-22.270327,"twenty":-22.323196,"median":-13.732985,"eighty":-9.124493,"marketCap":6933888522},{"date":"2026-04-10","current":-22.904899,"twenty":-22.318613,"median":-13.732985,"eighty":-9.124493,"marketCap":7131463115},{"date":"2026-04-17","current":-22.587613,"twenty":-22.31602,"median":-13.732985,"eighty":-9.124493,"marketCap":7032675819},{"date":"2026-04-24","current":-22.857699,"twenty":-22.31602,"median":-13.732985,"eighty":-9.124493,"marketCap":7116767484},{"date":"2026-05-01","current":-21.011634,"twenty":-22.281865,"median":-13.732985,"eighty":-9.124493,"marketCap":6618748881},{"date":"2026-05-08","current":-22.099591,"twenty":-22.131175,"median":-13.732985,"eighty":-9.124493,"marketCap":6961459672},{"date":"2026-05-15","current":-22.065644,"twenty":-22.052131,"median":-13.732985,"eighty":-9.124493,"marketCap":6950766186},{"date":"2026-05-22","current":-21.049841,"twenty":-21.895877,"median":-13.732985,"eighty":-9.124493,"marketCap":6630784168},{"date":"2026-05-29","current":-21.271803,"twenty":-21.811404,"median":-13.727031,"eighty":-9.115738,"marketCap":6700703118},{"date":"2026-06-05","current":-19.48305,"twenty":-21.578881,"median":-13.732985,"eighty":-9.124493,"marketCap":6137238640},{"date":"2026-06-12","current":-21.663501,"twenty":-21.439081,"median":-13.732985,"eighty":-9.124493,"marketCap":6824089500},{"date":"2026-06-18","current":-23.475756,"twenty":-21.439081,"median":-13.732985,"eighty":-9.124493,"marketCap":7394957161},{"date":"2026-06-26","current":-30.411419,"twenty":-21.412034,"median":-13.727031,"eighty":-9.115738,"marketCap":9579718698},{"date":"2026-07-02","current":-29.821261,"twenty":-21.412034,"median":-13.727031,"eighty":-9.115738,"marketCap":9393816549},{"date":"2026-07-10","current":-31.074694,"twenty":-21.412034,"median":-13.727031,"eighty":-9.115738,"marketCap":9788652972},{"date":"2026-07-17","current":-29.766423,"twenty":-21.412034,"median":-13.727031,"eighty":-9.115738,"marketCap":9376542456},{"date":"2026-07-24","current":-28.823737,"twenty":-21.412034,"median":-13.727031,"eighty":-9.115738,"marketCap":9079592563},{"date":"2026-07-31","current":-27.943723,"twenty":-21.396942,"median":-13.721078,"eighty":-9.106984,"marketCap":8802384491},{"date":"2026-08-07","current":-29.532803,"twenty":-21.396942,"median":-13.721078,"eighty":-9.106984,"marketCap":8848057261},{"date":"2026-08-14","current":-31.755881,"twenty":-21.396942,"median":-13.721078,"eighty":-9.106984,"marketCap":9514093711},{"date":"2026-08-21","current":-33.720849,"twenty":-21.396942,"median":-13.721078,"eighty":-9.106984,"marketCap":10102800087},{"date":"2026-08-28","current":-33.368376,"twenty":-21.396942,"median":-13.721078,"eighty":-9.106984,"marketCap":9997198802},{"date":"2026-08-31","current":-32.791097,"twenty":-21.396942,"median":-13.721078,"eighty":-9.106984,"marketCap":9824245516}],"updateTime":1788289654679},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KYMR\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2628242178","title":"Kymera Therapeutics Chief Business Officer Noah Goodman sells 1,347 shares for $121,230","url":"https://stock-news.laohu8.com/highlight/detail?id=2628242178","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628242178?lang=en_us&edition=fundamental","pubTime":"2026-04-17 06:30","pubTimestamp":1776378642,"startTime":"0","endTime":"0","summary":"Kymera Therapeutics Chief Business Officer Noah Goodman sold 1,347 shares on April 14, 2026 at USD 90 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kymera Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 16, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nNDL6lRcyN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KYMR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628242523","title":"Kymera director Bruce Booth disposes of common shares worth $836,290.08","url":"https://stock-news.laohu8.com/highlight/detail?id=2628242523","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628242523?lang=en_us&edition=fundamental","pubTime":"2026-04-17 06:17","pubTimestamp":1776377857,"startTime":"0","endTime":"0","summary":"Kymera Therapeutics director Bruce Booth disclosed sales of 8,559 shares on April 14-15.Disposals were reported at prices ranging from USD 89.95 to USD 90.10 per share.Booth reported 0 shares owned directly following transactions.Holdings reported indirectly were 3,899,917 shares and 674,956 shares following sales.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kymera Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 16, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nNDL1xJvvH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Kymera director Bruce Booth disposes of common shares worth $836,290.08","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KYMR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627450630","title":"BUZZ-U.S. STOCKS ON THE MOVE-Conagra, Oracle, Replimune","url":"https://stock-news.laohu8.com/highlight/detail?id=2627450630","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627450630?lang=en_us&edition=fundamental","pubTime":"2026-04-14 01:50","pubTimestamp":1776102619,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Conagra, Oracle, ReplimuneWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: htt","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nL6N40W0LU:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HPE","EMN","ADBE","DOW","MARA","CVX","IBM","NEM","BBY","LUV","GFL","HP","APP","BIIB","CAG","XOM","LYB","HUT","UAL","COIN","DIOD","LEG","AVT","META","OXY","ANIP","APTV","PINS","SNDK","GOOGL","ORCL","OCUL","CRM","REPL","SBUX","RIOT","IDYA","IMA","SYRE","DAL","GPRO","HL","KYMR","TFX","ALLO","RVMD","DVN","CDE","NOW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627144454","title":"BUZZ-U.S. STOCKS ON THE MOVE-Allogene Therapeutics, Adobe, Williams-Sonoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2627144454","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627144454?lang=en_us&edition=fundamental","pubTime":"2026-04-13 23:43","pubTimestamp":1776095026,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Allogene Therapeutics, Adobe, Williams-SonomaWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News C","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nL6N40W0Y7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DIOD","RVMD","IDYA","SYRE","IMA","META","DVN","SBU","CRWV","ANIP","HUT","BBY","ALLO","LYB","SBUX","DOW","ADBE","MARA","GPRO","CDE","SNDK","COIN","TFX","EMN","KYMR","CVX","UAL","XOM","LUV","HTFL","AAL","CAG","OXY","OWL","APTV","AVT","IBM","DAL","GOOGL","HL","LEG","HPE","WSM","BIIB","RIOT","REPL","OCUL","PINS","NEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627437896","title":"FDA grants fast track designation to Kymera Therapeutics KT-621","url":"https://stock-news.laohu8.com/highlight/detail?id=2627437896","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627437896?lang=en_us&edition=fundamental","pubTime":"2026-04-13 19:13","pubTimestamp":1776078812,"startTime":"0","endTime":"0","summary":"Kymera Therapeutics (KYMR) announced that the FDA has granted fast track designation to KT-621, its oral STAT6 degrader, for the treatment of moder...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fda-grants-fast-track-designation-to-kymera-therapeutics-kt-621-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fda-grants-fast-track-designation-to-kymera-therapeutics-kt-621-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KT","BK4139","LABU","LU0541502299.USD","BK4585","BK4115","SG9999004220.SGD","KYMR","LU0541501648.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627743294","title":"Kymera says FDA grants Fast Track designation for KT-621 in eosinophilic asthma","url":"https://stock-news.laohu8.com/highlight/detail?id=2627743294","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627743294?lang=en_us&edition=fundamental","pubTime":"2026-04-13 19:01","pubTimestamp":1776078110,"startTime":"0","endTime":"0","summary":"Kymera Therapeutics secured FDA Fast Track designation for KT-621, its oral STAT6 degrader, in moderate to severe eosinophilic asthma.Phase 2b BREADTH asthma study remains ongoing, with results expected in late 2027.Development plan also includes Phase 2b BROADEN2 trial in moderate to severe atopic dermatitis, with results expected by mid-2027.Earlier findings from BroADen Phase 1b in atopic dermatitis patients indicated improvement in asthma-related disease control in a subset with comorbid asthma.Fast Track status could support a faster path to later-stage registration studies if upcoming trials confirm clinical benefit.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nNDL3Q4HP1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","SG9999014013.SGD","KYMR","NDAQ","LU0314104364.USD","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","LU2210149790.SGD","IE00BGHQF748.EUR","SG9999014039.USD","IE00BN0W2T93.GBP","LU2095319765.USD","LU2210150020.SGD","IE00BN0W2W23.USD","BK4112","IE00BN0W2V16.EUR","SG9999014005.SGD","BK4585","BK4588","BK4139","IE00BKPKM429.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627432953","title":"Kymera Therapeutics Inc - KT-621 Broaden2 Phase 2B Atopic Dermatitis Trial Ongoing, Data Expected by Mid-2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2627432953","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627432953?lang=en_us&edition=fundamental","pubTime":"2026-04-13 19:00","pubTimestamp":1776078001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nTUA20DP0R:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KYMR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627329814","title":"Kymera Therapeutics Announces U.S. FDA Fast Track Designation for KT-621, a First-in-Class, Oral Stat6 Degrader for the Treatment of Moderate to Severe Asthma","url":"https://stock-news.laohu8.com/highlight/detail?id=2627329814","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627329814?lang=en_us&edition=fundamental","pubTime":"2026-04-13 19:00","pubTimestamp":1776078001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nTUA20DP0R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KYMR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626148089","title":"Kymera CBO Noah Goodman disposes of common shares worth $893,260.62","url":"https://stock-news.laohu8.com/highlight/detail?id=2626148089","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626148089?lang=en_us&edition=fundamental","pubTime":"2026-04-11 04:46","pubTimestamp":1775853982,"startTime":"0","endTime":"0","summary":"Noah Goodman, chief business officer, reported sales of 10,264 Kymera Therapeutics shares on April 9-10.Sale prices ranged from USD 86.62 to USD 89 per share.He also exercised options for 2,500 shares at USD 21.05 on April 9.Directly held Kymera shares fell to 51,542 following transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kymera Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 10, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nNDL9C45xm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Kymera CBO Noah Goodman disposes of common shares worth $893,260.62","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KYMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626231134","title":"BUZZ-U.S. STOCKS ON THE MOVE-Amazon, Northrop Grumman, Brown-Forman","url":"https://stock-news.laohu8.com/highlight/detail?id=2626231134","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626231134?lang=en_us&edition=fundamental","pubTime":"2026-04-10 01:51","pubTimestamp":1775757106,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Amazon, Northrop Grumman, Brown-FormanWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call new","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nL6N40S0MV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CORD","HRL","TSLG","APLD","CRSH","CRWU","TEMT","RELL","MRVU","CG","CRWG","MVLL","ANVS","MRVL","TSLO","TSLQ","VNDA","TSLR","STAA","NUAI","TSLA","CAT","TSLS","TEM","BLSX","BLSH","FDX","ADSK","SMPL","GLMD","STZ","NRGV","WW","TSLL","KYMR","NOC","NOW","CRWV","BLSG","CCCC","TSL","GDRX","TSLP","FBRX","TSLI","AMZN","OXY","AZYY","WSR","IDYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626318962","title":"BUZZ-Kymera rises as Gilead pays $45 million for experimental cancer drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2626318962","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626318962?lang=en_us&edition=fundamental","pubTime":"2026-04-09 19:20","pubTimestamp":1775733628,"startTime":"0","endTime":"0","summary":"BUZZ-Kymera rises as Gilead pays $45 million for experimental cancer drug** Shares of biotech firm Kymera Therapeutics KYMR.O rise 3% to $89.50 premarket** Co says it will receive $45 million upfront from Gilead Sciences GILD.O to license KT-200, an experimental oral cancer drug** KT-200 targets CDK2, a protein that helps tumors grow; the drug is designed to remove the protein entirely, which could improve effectiveness and reduce side effects - KYMR** Co says the drug could help treat hardtotreat cancers such as advanced breast cancer, where treatment options are limited** Adds that Gilead gets global rights and will lead further development, aiming to start human studies in 2027** Says Kymera could receive up to $750 million in total payments plus royalties if the drug is approved** As of last close, stock up ~12% YTD","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nL4N40S0V1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1585245621.USD","LU0289739699.SGD","LU2468319806.SGD","BK4566","KYMR","BK4578","LU1934455277.USD","LU0114720955.EUR","LU0320765992.SGD","LU2087621335.USD","LU0109394709.USD","IE00BSNM7G36.USD","LU1934455194.USD","LU0234570918.USD","LU1037948541.HKD","LU1839511570.USD","LU1430594728.SGD","BK4139","SG9999015978.USD","LU2324357040.USD","LU1061106388.HKD","LU1674673691.USD","GILD","BK4588","SG9999015945.SGD","LU0058720904.USD","LU2112291526.USD","SG9999015952.SGD","LU1066051498.USD","BK4568","IE00B19Z3581.USD","LU1571399168.USD","BK4550","IE00B7SZLL34.SGD","LU1934455863.HKD","LU0965509010.AUD","IE00B3T34201.USD","LU0861579265.USD","LU0882574055.USD","IE00BKVL7J92.USD","LU1674673428.USD","LU1023059063.AUD","LU2089984988.USD","LU0889565916.HKD","IE00BZ1G4Q59.USD","BK4583","LU1057294990.SGD","LU1066053197.SGD","LU0965508806.USD","IE0002270589.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626818648","title":"Kymera Therapeutics Inc - Gilead to Advance KT-200 Into Ind-Enabling Studies for 2027 Ind Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2626818648","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626818648?lang=en_us&edition=fundamental","pubTime":"2026-04-09 19:00","pubTimestamp":1775732404,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nTUA7RQDRS:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KYMR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626186968","title":"Kymera Therapeutics Inc - to Receive $45 Mln Milestone Payment From Gilead for KT-200 Option","url":"https://stock-news.laohu8.com/highlight/detail?id=2626186968","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626186968?lang=en_us&edition=fundamental","pubTime":"2026-04-09 19:00","pubTimestamp":1775732404,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nTUA7RQDRS:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KYMR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626186960","title":"Kymera Therapeutics Inc - May Receive Tiered Royalties From High Single-Digit to Mid-Teens on Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2626186960","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626186960?lang=en_us&edition=fundamental","pubTime":"2026-04-09 19:00","pubTimestamp":1775732404,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nTUA7RQDRS:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KYMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626186913","title":"Kymera Therapeutics Inc - Eligible for up to $750 Mln in Total Payments Under Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2626186913","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626186913?lang=en_us&edition=fundamental","pubTime":"2026-04-09 19:00","pubTimestamp":1775732404,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nTUA7RQDRS:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KYMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626186243","title":"Kymera Therapeutics Announces Gilead Sciences’ Option Exercise to License KT-200, Oral CDK2 Molecular Glue Degrader Development Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2626186243","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626186243?lang=en_us&edition=fundamental","pubTime":"2026-04-09 19:00","pubTimestamp":1775732400,"startTime":"0","endTime":"0","summary":"KT-200 is a first-in-class, oral CDK2 molecular glue degrader development candidate Option exercise of KT-200 triggers a $45 million milestone payment to Kymera from Gilead Sciences WATERTOWN, Mass., ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/09/3270789/0/en/Kymera-Therapeutics-Announces-Gilead-Sciences-Option-Exercise-to-License-KT-200-Oral-CDK2-Molecular-Glue-Degrader-Development-Candidate.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","IE00BZ1G4Q59.USD","LU1934455194.USD","LU0861579265.USD","LU0823416689.USD","LU1066053197.SGD","BK4585","LU1571399168.USD","GILD","LU0965508806.USD","LU1061106388.HKD","BK4566","LU0234570918.USD","LU1674673428.USD","LU1934455863.HKD","BK4550","LU2324357040.USD","LU1430594728.SGD","IE00B7SZLL34.SGD","LU1778281490.HKD","LU0109394709.USD","BK4588","LU1674673691.USD","LU0058720904.USD","KYMR","BK4568","LU0882574055.USD","BK4583","LU1023059063.AUD","LU2468319806.SGD","SG9999015986.USD","IE00B19Z3B42.SGD","BK4115","BK4578","IE00BKVL7J92.USD","SG9999015952.SGD","LU2089984988.USD","IE00BSNM7G36.USD","SG9999015978.USD","LU1585245621.USD","LU0114720955.EUR","SG9999015945.SGD","LU0122379950.USD","LU0965509010.AUD","IE00B19Z3581.USD","LU0541501648.USD","IE0002270589.USD","LU1057294990.SGD","LU0889565916.HKD","KT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624547703","title":"Kymera COO Jeremy G Chadwick disposes of USD 1.9 million common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2624547703","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624547703?lang=en_us&edition=fundamental","pubTime":"2026-04-02 07:00","pubTimestamp":1775084450,"startTime":"0","endTime":"0","summary":"Kymera Therapeutics Chief Operating Officer Jeremy G. Chadwick cut direct holdings to 61,202 shares.Chadwick sold 22,240 shares on March 31 and April 1 at prices around $85.38 to $86.05.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kymera Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 01, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nNDL27Tv6f:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Kymera COO Jeremy G Chadwick disposes of USD 1.9 million common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KYMR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624154770","title":"Kymera director Elena Ridloff disposes of USD 1.3 million common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2624154770","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624154770?lang=en_us&edition=fundamental","pubTime":"2026-04-02 07:00","pubTimestamp":1775084449,"startTime":"0","endTime":"0","summary":"Kymera Therapeutics director Elena Ridloff sold 13,000 shares on March 31-April 1.Sales were priced at about $85.37 per share on March 31.Additional shares sold April 1 were priced at about $85.19-$86.05 per share.Ridloff’s direct holdings fell to 0 shares following transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kymera Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 01, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nNDL4nXBBN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KYMR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623662643","title":"How Investors Are Reacting To Kymera Therapeutics (KYMR) Oral STAT6 Degrader’s Positive Phase 1b Atopic Dermatitis Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2623662643","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623662643?lang=en_us&edition=fundamental","pubTime":"2026-03-30 07:07","pubTimestamp":1774825626,"startTime":"0","endTime":"0","summary":"Kymera Therapeutics recently reported past positive Phase 1b data for KT-621, its first-in-class oral STAT6 degrader in moderate-to-severe atopic dermatitis, showing deep STAT6 reduction, broad biomarker effects and encouraging clinical improvements after 28 days of once-daily dosing.\nThe data, presented as a late-breaking oral session at the American Academy of Dermatology meeting, highlight how Kymera’s protein degradation platform may translate into biologics-like immune modulation using...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-kymr/kymera-therapeutics/news/how-investors-are-reacting-to-kymera-therapeutics-kymr-oral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-kymr/kymera-therapeutics/news/how-investors-are-reacting-to-kymera-therapeutics-kymr-oral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ISBC","BK4139","BK4211","KYMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622382816","title":"Kymera says oral STAT6 degrader KT-621 shows positive Phase 1b atopic dermatitis data","url":"https://stock-news.laohu8.com/highlight/detail?id=2622382816","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622382816?lang=en_us&edition=fundamental","pubTime":"2026-03-28 23:00","pubTimestamp":1774710015,"startTime":"0","endTime":"0","summary":"Kymera highlighted Phase 1b BroADen trial results for KT-621 in a late-breaking oral session at American Academy of Dermatology annual meeting on March 28, 2026.BroADen enrolled 22 moderate-to-severe atopic dermatitis patients in a single-arm, open-label design with once-daily oral dosing for 28 days.KT-621 produced deep STAT6 degradation, with median reductions of 94% in skin and 98% in blood across 100 mg and 200 mg cohorts.Clinical readouts showed mean 63% reduction in EASI score, with 29% of patients reaching EASI-75.Kymera’s ongoing Phase 2b trials include BROADEN2 in atopic dermatitis with data expected by mid-2027, with asthma study BREADTH reading out in late-2027.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260328:nNDL91sPNX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","IE00BN0W2T93.GBP","NDAQ","IE00BKPKM429.USD","IE00BN0W2V16.EUR","LU2095319765.USD","LU2210149790.SGD","SG9999014039.USD","LU0314104364.USD","SG9999014005.SGD","SG9999014021.USD","BK4588","IE00B64PRP62.GBP","BK4139","SG9999014013.SGD","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","BK4585","BK4112","IE00BN0W2W23.USD","KYMR"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":7,"totalSize":149,"code":"91000000","status":"200"}]}}